DNER and colorectal carcinoma: A recent study showed that BET inhibitor inhibits CSC properties of CRC cells, and BET inhibitors can reduce the level of CSCs and their stem cell-like features, which suggest that the use of this molecule for targeting CSCs in glioma17.